BDNF and Angelman syndrome: In Angelman syndrome, where BDNF signaling is impaired (Cao et al., 2013), CN2097 enhanced BDNF signaling to restore long-term potentiation and mitigate neurological deficits (Cao et al., 2013; Lau et al., 2023).